|
|
INFLUX
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/28/2026 15:29
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization6,023.73 mln
Beneish M-Score
-1.15
Manipulation likely
Relative Strength
87
/ 100
Strongly outperforming
Key Fundamentals
EPS9.35
P/E28.66
ROE21.51
ROIC29.19
ROA17.31
Interest Cover142
EBITDA, mln312
EV / EBITDA18.63
EV / EBIT21.20
Revenue, mln1,468
EV / Revenue3.96
Quote Details
Last
270.05
Change
16.2 (6.38%)
Open
259.95
Volume
25,800
Turnover
6,967,290
Average Volume
31,429
Financial Ratios
Pre-Tax Profit Margin19
Current Ratio3.59
Price / Book5.98
Price / Tangible Book5.98
Price / Sales4.10
Financial Strength
Altman Z-Score18.4
Piotroski F-Score
6
/ 9
Beneish M-Score-1.15
Price to Graham Number4.00
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.82% |
83
/ 100
 |
| 1 Month |
-4.05% |
67
/ 100
 |
| 2 Months |
-9.98% |
43
/ 100
 |
| 6 Months |
7.46% |
72
/ 100
 |
| 1 Year |
55.2% |
91
/ 100
 |
|
| |
